PGA
GILD icon

Premia Global Advisors’s Gilead Sciences GILD Stock Holding History

Premia Global Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-203
Closed -$13K – 187
2019
Q1 		$13K Buy
+203
New +$13.5K 0.01% 322
2018
Q2 		– Sell
-421
Closed -$31K – 259
2018
Q1 		$31K Sell
421
-2,360
-85% -$188K 0.03% 250
2017
Q4 		$198K Buy
+2,781
New +$211K 0.19% 133

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Premia Global Advisors's GILD Position: Q2 2019 in Review

Premia Global Advisors sold out of Gilead Sciences (GILD) in Q2 2019, closing a stake of 203 shares — an estimated $13K sold.

Premia Global Advisors first reported a position in GILD in Q4 2017 and held it in 3 quarters. The position peaked at $198K in Q4 2017. 1,483 funds tracked by Wall St. Rank hold GILD as of Q2 2019.

  • Premia Global Advisors reported no remaining Gilead Sciences position as of Q2 2019 after selling out during the quarter.
  • Premia Global Advisors sold 203 Gilead Sciences shares in Q2 2019, an estimated $13K.
  • Premia Global Advisors first reported a position in Gilead Sciences in Q4 2017 and held it in 3 quarters.
  • Premia Global Advisors's Gilead Sciences position peaked at $198K in Q4 2017.
  • 1,483 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2019.

Based on Premia Global Advisors's 13F filing for Q2 2019, filed 13 Aug 2019.